Sign in
Home
Biz News
New Products
Cell Therapy
Medical Devices
Journal Papers
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, January 16, 2025
Sign in / Join
Contact
About
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Cell Tribune: Cell and Gene Therapy News and Research
Home
Biz News
U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01 Study
New Antimicrobial Resistance (AMR) Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion
Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory T cell therapy in autoimmune and degenerative diseases
Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients
Sigilon Therapeutics approaches the clinic
New Products
CAR-T cell therapy benefits limited to few patients because of ‘Insurance Snags’
Helix BioPharma Corp. announces the signing of a non-binding letter of intent with ProMab Biotechnologies to develop cell based therapies
Cell Therapy
Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory T cell therapy in autoimmune and degenerative diseases
Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients
Sigilon Therapeutics approaches the clinic
MilliporeSigma Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing
ReNeuron Presents Positive Clinical Data at the American Academy of Ophthalmology Annual Meeting
Medical Devices
CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy
Intarcia Therapeutics Secures Additional $206M Financing; Gates Foundation to Invest up to $140M in Grants and Equity
Bionic Pancreas System Successfully Controls Blood Sugar Without Risk of Hypoglycemia
Journal Papers
Immunotherapy gel targets lingering tumor cells after surgery
‘Decorated’ Stem Cells Could Offer Targeted Heart Repair
Stem cell biologist at Harvard retracts diabetes breakthrough manuscript published in Cell citing reproducibility issues
PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche
Business
Cell Therapy
Clinical Trials
Events
Gene Therapy
Health
Immunotherapy
Intellectual Property
Journal Papers
Manufacturing
Medical Devices
New Products
People and Career
Pharma
Technology
Video
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Twenty-two New Patents Are Added To ViaCyte’s Intellectual Property Portfolio
Cell Tribune
-
January 4, 2017
0
Intellectual Property
Home
Intellectual Property
59
Followers
Follow
EDITOR PICKS
GBT Receives FDA Breakthrough Therapy Designation for Voxelotor for Treatment of Sickle Cell Disease...
Cell Tribune
-
January 10, 2018
CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy
Cell Tribune
-
September 17, 2018
Purdue Pharma and Exicure Announce Strategic Research Collaboration Agreement to Discover and Develop a...
Cell Tribune
-
December 13, 2016
FDA Clears Pluristem’s Expanded Access Program to Initiate Treatments of Critical Limb Ischemia Outside...
Cell Tribune
-
January 9, 2018
